Together, they will find partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal platform used for precisely targeting specific regions of the nasal cavity.

To install a new sterile filling line, significantly increasing its production capacity for sterile vials or freeze-drying.